← Back to Search

SHIFT Onboard Intervention for Obesity (SHIFTOnboard Trial)

N/A
Waitlist Available
Led By Ryan Olson, PhD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 and 24 months
Awards & highlights

SHIFTOnboard Trial Summary

This trial will test whether an occupational health intervention can help newly hired bus operators avoid weight gain and improve job success.

SHIFTOnboard Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Mass Index
Change from baseline in actigraphically measured physical activity at 12 and 24 months
Change from baseline in actigraphically measured sleep quality at 12 and 24 months
+10 more
Secondary outcome measures
Absenteeism
Bus collisions
Changes in intention to remain at job
+7 more
Other outcome measures
Baseline body weight as a moderator of intervention effects on weight at follow-ups
Change from baseline in HDL cholesterol
Change from baseline in Hemoglobin A1c at 12 and 24 months
+5 more

SHIFTOnboard Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SHIFT Onboard InterventionExperimental Treatment1 Intervention
A 12-month onboarding process and social challenge supported with goal setting, computer-based training, self-monitoring, and group motivational interviewing.
Group II: Usual Practice ControlActive Control1 Intervention
Participants experience standard or "Usual Practices" in new employee onboarding processes at their workplace.

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,834 Previous Clinical Trials
47,310,351 Total Patients Enrolled
251 Trials studying Obesity
205,772 Patients Enrolled for Obesity
Oregon Health and Science UniversityLead Sponsor
973 Previous Clinical Trials
6,845,745 Total Patients Enrolled
29 Trials studying Obesity
9,062 Patients Enrolled for Obesity
Ryan Olson, PhD5.0141 ReviewsPrincipal Investigator - Oregon Health and Science University
Medical School - Des Moines University, Doctor of Osteopathic Medicine
Legacy Emanuel Hospital & Health Center (Residency)
5Patient Review
This doctor is the best!

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What primary goals are being sought with this investigation?

"This trial is expected to last two years and will assess whether there has been a change from the baseline in self-reported sleep quantity. Additionally, the secondary outcomes evaluated include perceived acceptance by others as determined through surveys; job role conflict assessed via surveys; and bus collisions monitored according to organizational records."

Answered by AI

What is the capacity of enrollees for this trial?

"Affirmative. According to clinicaltrials.gov, this medical trial has been accepting enrollees since July 15th 2019 and was recently updated on February 4th 2020. 284 participants are required for the study which is taking place at a single site."

Answered by AI

Is this clinical experiment presently open to enrolment?

"Confirmed. Clinicaltrials.gov shows that the trial in question is actively looking for participants, having first been posted on July 15th 2019 and last updated February 4th 2020. This research seeks to recruit 284 patients from a single location."

Answered by AI
~49 spots leftby Apr 2025